Skip to main content

scPharmaceuticals Inc.

SCPHDelisted Oct 7, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001604950

scPharmaceuticals Inc. was delisted on Oct 7, 2025; its insiders filed their last Form 4 on Oct 7, 2025; 110 institutions reported holding it in 13F filings for Q3 2025, worth $232.3M in total; no superinvestor held it.

13F holders, Q4 2024

Institutional positions in scPharmaceuticals Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
86
−8 vs. Q3 2024
Shares held
39.8M
+2.60M (+7.0%) vs. Q3 2024
Total value
$140.8M
−$28.6M (−16.9%) vs. Q3 2024
New holders
18
37 more added
Sold out
26
16 more reduced

1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting SCPH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2024: 86 institutions
Q1 2021: 46 institutionsQ2 2021: 38 institutionsQ3 2021: 31 institutionsQ4 2021: 33 institutionsQ1 2022: 37 institutionsQ2 2022: 38 institutionsQ3 2022: 40 institutionsQ4 2022: 59 institutionsQ1 2023: 63 institutionsQ2 2023: 81 institutionsQ3 2023: 73 institutionsQ4 2023: 81 institutionsQ1 2024: 76 institutionsQ2 2024: 77 institutionsQ3 2024: 95 institutionsQ4 2024: 86 institutionsQ1 2025: 88 institutionsQ2 2025: 98 institutionsQ3 2025: 110 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ4 2024: $140.8M
Q1 2021: $114.1MQ2 2021: $97.9MQ3 2021: $107.9MQ4 2021: $80.0MQ1 2022: $90.1MQ2 2022: $75.9MQ3 2022: $91.3MQ4 2022: $153.5MQ1 2023: $223.2MQ2 2023: $290.8MQ3 2023: $213.1MQ4 2023: $175.4MQ1 2024: $134.2MQ2 2024: $121.0MQ3 2024: $169.8MQ4 2024: $140.8MQ1 2025: $98.7MQ2 2025: $145.7MQ3 2025: $232.3MQ4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding SCPH and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 2025110$232.3M
Q2 202598$145.7M
Q1 202588$98.7M
Q4 202486$140.8M
Q3 202495$169.8M
Q2 202477$121.0M
Q1 202476$134.2M
Q4 202381$175.4M
Q3 202373$213.1M
Q2 202381$290.8M
Q1 202363$223.2M
Q4 202259$153.5M
Q3 202240$91.3M
Q2 202238$75.9M
Q1 202237$90.1M
Q4 202133$80.0M
Q3 202131$107.9M
Q2 202138$97.9M
Q1 202146$114.1M

Institutions, Q4 2024

Shares, value and share of portfolio for each institution holding scPharmaceuticals Inc.; share changes are against Q3 2024.

Institutions holding SCPH in Q4 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Simplex Trading, LLC0$00.00%−14,618−100.0%Sold out
Manufacturers Life Insurance Company, The0$00.00%−12,411−100.0%Sold out
Sanctuary Advisors, LLC0$00.00%−16,555−100.0%Sold out
Voya Investment Management LLC0$00.00%−11,389−100.0%Sold out
Pinnacle Wealth Planning Services, Inc.0$00.00%−11,232−100.0%Sold out
Virtu Financial LLC0$00.00%−10,105−100.0%Sold out
Acadian Asset Management LLC0$00.00%−9,060−100.0%Sold out
Russell Investments Group, Ltd.0$00.00%−449−100.0%Sold out
GAMMA Investing LLC0$00.00%−265−100.0%Sold out
Covestor Ltd0$00.00%−151−100.0%Sold out
Capital Performance Advisors LLP0$00.00%−85−100.0%Sold out
International Assets Investment Management, LLC0$00.00%−456−100.0%Sold out
Raymond James & Associates––––Not filed